跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,561 条关于
“FR104/VEL-101”
全部
15,561
临床试验
8,074
药物
5,347
机构
108
资讯
2,032
去年
OSE Immunotherapeutics Announces Positive H1 2024 Results and Corporate Updates
去年
OSE Immunotherapeutics Reports Strong Financial Results and Pipeline Progress in 2024
去年
Veloxis Pharmaceuticals' Transplant Candidate VEL-101 Receives Official Name "Pegrizeprument"
4个月前
FDA Grants Orphan Drug Designation to Pegrizeprument for Heart Transplant Rejection Prevention
8个月前
FDA Grants Orphan Drug Designation to Pegrizeprument for Liver Transplant Rejection Prevention
18天前
Veloxis Doses First Patient in Phase 2 RENGEVITY-201 Trial of Pegrizeprument for Kidney Transplant Rejection Prevention
11个月前
Vascarta Completes Phase 1 Trial of Topical Curcumin Gel VAS-101 for Knee Osteoarthritis
去年
Endeavor BioMedicines' ENV-101 Shows Promise in Reversing Idiopathic Pulmonary Fibrosis in Phase II Trials
5个月前
Vascarta's Topical Curcumin Gel VAS-101 Shows Significant Pain Reduction in Knee Osteoarthritis Phase 1b Trial
去年
Galimedix Therapeutics Initiates Phase 2 Trial of GAL-101 Eye Drops for Dry AMD
第 1 页,共 204 页
上一页
下一页